New treatments are on the horizon for ankylosing spondylitis and two other debilitating conditions that affect up to three per cent of the global population – thanks to a research and development deal involving University of Queensland research.
University of Queensland researchers have developed a world-first vaccine-style therapeutic approach to treat rheumatoid arthritis, a debilitating disease affecting more than 450,000 people in Australia.
Dr Andrew Brooks is part of an international team of scientists who have determined that unstructured parts of Class 1 cytokine receptors are able to interact with the inner membrane of cells.
In a study published this month in the journal Blood, UQDI’s Professor Maher Gandhi and his colleagues at Stanford University have revealed a new technique that enables early detection of non-Hodgkin lymphoma.
Breast cancer research at The University of Queensland Diamantina Institute is bypassing the tumour and focusing on the environment in which the cancer lives.
University of Queensland research has shown that a high-cholesterol diet increases the spread of prostate cancer tumours to lymph nodes, lungs and bones.
Bridgestone has presented its inaugural Career Establishment Grant to a Queensland researcher to help find a cure for blood cancer – a disease which strikes 31 Australians daily.
University of Queensland research to prevent, treat and diagnose a range of cancers has been boosted by the injection of $1.78 million in Cancer Council Queensland funding.
